TEXAS INSTRUMENTS INC — Director's Dealing 2019

May 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TEXAS INSTRUMENTS INC (TXN)
CIK: 0000097476
Period of Report: 2019-04-29

Reporting Person: TEMPLETON RICHARD K (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-29	Common Stock	M	160000	$32.36	Acquired	930287	Direct
2019-04-29	Common Stock	S	150799	$116.7558	Disposed	779488	Direct
2019-04-29	Common Stock	S	9201	$117.0758	Disposed	770287	Direct
2019-04-30	Common Stock	M	160000	$32.36	Acquired	930287	Direct
2019-04-30	Common Stock	S	38161	$117.4294	Disposed	892126	Direct
2019-04-30	Common Stock	S	121839	$117.8819	Disposed	770287	Direct
2019-05-01	Common Stock	M	155000	$32.36	Acquired	925287	Direct
2019-05-01	Common Stock	S	28212	$116.8229	Disposed	897075	Direct
2019-05-01	Common Stock	S	120222	$117.7312	Disposed	776853	Direct
2019-05-01	Common Stock	S	6566	$118.4323	Disposed	770287	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-29	NQ Stock Option (Right to Buy)	$32.36	M	160000	Disposed	2022-01-26	Common Stock (160000)	Direct
2019-04-30	NQ Stock Option (Right to Buy)	$32.36	M	160000	Disposed	2022-01-26	Common Stock (160000)	Direct
2019-05-01	NQ Stock Option (Right to Buy)	$32.36	M	155000	Disposed	2022-01-26	Common Stock (155000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	46551	Indirect
Common Stock	12783.5615	Indirect
Common Stock	310.404	Indirect

Footnotes

F1: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $116.02 to $117.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $117.02 to $117.25. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $116.64 to $117.635. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F4: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $117.64 to $118.355. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F5: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $116.24 to $117.235. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F6: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $117.24 to $118.23. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F7: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $118.24 to $118.81. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F8: Beneficial ownership by reporting person disclaimed.

F9: Estimated shares attributable to TI Universal Profit Sharing Account as of 03-31-2019. (Interests in this account are denominated in units. Consequently, share amount shown is an estimate.) This statement does not include changes in beneficial ownership of shares held in such account occurring after 03-31-2019 that are eligible for deferred reporting on Form 5.

F10: Estimated shares attributable to TI 401(k) Account as of 03-31-2019. (Interests in this account are denominated in units. Consequently, share amount shown is an estimate.) This statement does not include changes in beneficial ownership of shares held in this account occurring after 03-31-2019 that are eligible for deferred reporting on Form 5.

F11: The option became exercisable in four equal annual installments beginning on January 26, 2013.